Nephrology News

WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results of a study on renal transplant patients that found those with gout had increased rates of transplant-related complications.

WASHINGTON — Placement of an arteriovenous fistula in patients with chronic kidney disease not on dialysis can help stabilize GFR, according to a study presented here during ASN Kidney Week.

WASHINGTON — Data presented here at ASN Kidney Week showed patients who developed ESKD due to acute kidney injury had different outcomes based on sex and race.

WASHINGTON — Patients who chose in-center nocturnal hemodialysis at a large dialysis organization had improved solute clearance, lower ultrafiltration rates, improved nutritional parameters and lower hospitalization rates compared to patients who had conventional, in-center hemodialysis, according to results presented at ASN Kidney Week here.

WASHINGTON — Difelikefalin significantly reduced itch intensity and was linked to an increase in quality of life for patients on hemodialysis who had moderate to severe pruritus, according to phase 3 data presented at ASN Kidney Week.

WASHINGTON — Study results presented at ASN Kidney Week described the characteristics of patients who were more likely to be treated with insulin for hyperkalemia, a treatment which researchers argued is associated with longer hospital stays and increased mortality risk.

WASHINGTON — The RenalGuard System reduced the rate of acute kidney injury by 50% in patients who underwent cardiac surgery, according to data presented at ASN Kidney Week.

WASHINGTON — Roxadustat showed efficacy with no increased cardiovascular risk for patients with anemia from chronic kidney disease, according to pooled efficacy data presented here at ASN Kidney Week.

WASHINGTON — For patients on hemodialysis who eat rice as a main source of calories, low-protein rice plus low-phosphorus whey can reduce serum phosphorus and improve serum albumin, according to study results presented at ASN Kidney Week.

WASHINGTON — In patients receiving maintenance hemodialysis, acquired thrombotic factors contributed to recurrent arteriovenous fistula clotting, according to data presented at ASN Kidney Week.